Not exact matches
Frequent shots of the MIS protein are too expensive for broad
use, but they could help protect the reserve of
ovarian follicles in young
cancer patients.
In order to assess whether an improved diet could reduce the risk of
ovarian cancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United S
cancer in African - American women, Qin analyzed the diets of 415 women with
ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United S
cancer and 629 control
patients,
using data from the African - American
Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United S
Cancer Epidemiology Study, a population - based case - control study of
ovarian cancer in African - American women in 11 sites in the United S
cancer in African - American women in 11 sites in the United States.
TRINOVA - 2 is evaluating pegylated liposomal doxorubicin in combination with either placebo or trebananib in previously treated
patients with
ovarian cancer while TRINOVA - 3, also known as ENGOT - Ov2 and Gynecologic Oncology Group — 3001, is studying the
use of trebananib in front - line treatment adding it to carboplatin / paclitaxel.
In some cases such as
ovarian cancer, however, drug - free intervals are needed to allow
patient recovery from side effects, during which tumors can sometimes begin to grow again or develop resistance to the drugs being
used.
In lab experiments, the research team
used cell lines derived from 40
patient tumour samples to identify that CD151 contributes to the survival of cells of high - grade serous
ovarian cancer origin.
The researchers also are seeking other potential drug targets in the 50 percent of
patients who don't have high levels of the anti-death protein, as well as biomarkers in addition to CA125 that could be
used to screen for
ovarian cancer.
Sood and colleagues looked at samples from 80 cases of human
ovarian cancer grouped according to
patient stress
using the National Institutes of Health's Center for Epidemiological Studies Depression scale as a surrogate marker.
Though smaller in number, some
patients with advanced disease and carrying a BRCA mutation may benefit from the same targeted therapy being
used today in the clinic to successfully treat some
ovarian cancer patients.»
Notably, the researchers found that,
using their methods, highly reactive TILs could be obtained from some 90 % of the
ovarian cancer patients whose tumor samples they examined.
$ 1.8 M Supports
Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed
Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem Cell Transplant
Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways in the Development of
Ovarian Cancer GMNews.com - March 2, 2016 Differences in Type of Small Protein may further Elucidate Lung
Cancer Risk in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate
Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed
Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette
Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the Lung
Cancer Ribbon?
In addition, drugs called PARP inhibitors, which have been shown to benefit some
ovarian cancer patients with BRCA mutations, may be of
use for prostate
cancer patients with the gene defects.
Olaparib is a PARP inhibitor, which is already
used to treat certain
ovarian cancer patients and prevents damaged
cancer cells from repairing themselves after chemotherapy or radiotherapy.
We have made progress in the safe
use of advanced surgical procedures and can now combine surgery with heated intraperitoneal chemotherapy for selected
patients with
ovarian cancer.
February 10, 2015 New screening tool could speed development of
ovarian cancer drugs University of Chicago Medicine researchers have built a model system that
uses multiple cell types from
patients to rapidly test compounds that could block the early steps in
ovarian cancer metastasis.
University of Chicago Medicine researchers have built a model system that
uses multiple cell types from
patients to rapidly test compounds that could block the early steps in
ovarian cancer metastasis.
MD Anderson
cancer center
uses about 4 tablespoons of flax seeds daily to significantly lower testosterone in their
patients with androgen secreting
ovarian tumors.